BSX · 8-K · 20261007PR000064

Strategic Operating Structure

BOSTON SCIENTIFIC CORP · 2026-10-07 · Importance 31 · Surprise 42

Boston Scientific will establish three reportable segments effective January 1, 2027: Interventional Therapies, Rhythm Solutions and MedSurg. Interventional Therapies will include Interventional Cardiology, Vascular Therapies and Interventional Oncology & Embolization. Rhythm Solutions will include Electrophysiology, WATCHMAN and Cardiac Rhythm Management & Diagnostics, while MedSurg will include Endoscopy, Urology and Neuromodulation. The company said the structure is intended to enable faster decision-making and support strategic allocation of investments across its portfolio.

Key facts

• Boston Scientific will establish three reportable segments — Interventional Therapies, Rhythm Solutions and MedSurg — effective Jan. 1, 2027. source
• The new operating structure is designed to enable faster decision making and support strategic allocation of investments across the company’s portfolio. source
• Interventional Therapies will include the Interventional Cardiology, Vascular Therapies and Interventional Oncology & Embolization businesses. source
• Rhythm Solutions will include Electrophysiology, WATCHMAN and Cardiac Rhythm Management & Diagnostics. source
• MedSurg will include Endoscopy, Urology and Neuromodulation. source
• Boston Scientific has been a global medical technology leader for more than 45 years. source
• The company’s portfolio helps physicians diagnose and treat cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. source
• The press release was issued in Marlborough, Mass., on Oct. 7, 2026. source